Scarica l'app Stockscreener
4.69
0.42%
-0.02
Precedente Chiudi:
$4.71
Aprire:
$4.71
Volume 24 ore:
4,307
Relative Volume:
0.02
Capitalizzazione di mercato:
$7.17M
Reddito:
$8.62M
Utile/perdita netta:
$-6.15M
Rapporto P/E:
-0.4252
EPS:
-11.03
Flusso di cassa netto:
$-5.32M
1 W Prestazione:
-3.30%
1M Prestazione:
-9.46%
6M Prestazione:
+118.14%
1 anno Prestazione:
-8.75%
Intervallo 1D:
$4.60
$4.74
Intervallo di 1 settimana:
$4.3904
$4.87
Portata 52W:
$1.94
$12.32
Evoke Pharma Inc Stock (EVOK) Company Profile
Nome
Evoke Pharma Inc
Settore
Telefono
858-345-1494
Indirizzo
420 STEVENS AVENUE, SOLANA BEACH, CA
Confronta EVOK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
4.60 | 7.36M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
143.79 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.205 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.77 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.10 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-06-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | Ripresa | FBR & Co. | Buy |
| 2017-03-16 | Reiterato | Rodman & Renshaw | Buy |
| 2017-01-30 | Aggiornamento | Laidlaw | Neutral → Buy |
| 2017-01-05 | Aggiornamento | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | Reiterato | Rodman & Renshaw | Neutral |
| 2016-07-19 | Reiterato | FBR Capital | Outperform |
| 2016-07-19 | Downgrade | Noble Financial | Buy → Hold |
| 2016-07-18 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | Iniziato | Northland Capital | Outperform |
| 2016-03-14 | Reiterato | Ascendiant Capital Markets | Buy |
| 2016-02-17 | Ripresa | FBR Capital | Outperform |
| 2014-12-03 | Reiterato | MLV & Co | Buy |
| 2014-11-07 | Iniziato | MLV & Co | Buy |
| 2014-04-22 | Iniziato | Laidlaw | Buy |
| 2013-11-19 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Evoke Pharma Inc Borsa (EVOK) Ultime notizie
How currency fluctuations impact Evoke Pharma Inc. stockRate Hike & Technical Confirmation Trade Alerts - newser.com
Evoke Pharma Inc.’s volatility index tracking explainedEarnings Beat & Risk Controlled Stock Alerts - newser.com
Will Evoke Pharma Inc. stock return to pre crisis levelsTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - newser.com
Does Evoke Pharma Inc. fit your quant trading modelGlobal Markets & Technical Buy Zone Confirmations - newser.com
Real time alert setup for Evoke Pharma Inc. performanceDay Trade & Free Community Consensus Stock Picks - newser.com
Using data tools to time your Evoke Pharma Inc. exitMarket Trend Report & Consistent Income Trade Ideas - newser.com
Short interest data insights for Evoke Pharma Inc.Dollar Strength & Real-Time Market Trend Scan - newser.com
What to expect from Evoke Pharma Inc. in the next 30 daysDay Trade & Daily Profit Maximizing Tips - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Evoke Pharma (NASDAQ:EVOK) - Defense World
Will Evoke Pharma Inc. stock recover after recent drop2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Sector ETF performance correlation with Evoke Pharma Inc.Trade Entry Report & Verified Entry Point Signals - newser.com
Institutional scanner results for Evoke Pharma Inc.Breakout Watch & Verified High Yield Trade Plans - newser.com
How to monitor Evoke Pharma Inc. with trend dashboardsRecession Risk & Safe Capital Investment Plans - newser.com
What Fibonacci levels say about Evoke Pharma Inc. rebound2025 Market Overview & Growth Focused Investment Plans - newser.com
Is Evoke Pharma Inc a good long term investmentLarge Cap Stability Picks & Register for the Next Free Workshop - earlytimes.in
News impact scoring models applied to Evoke Pharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Evoke Pharma Inc Azioni (EVOK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):